Your browser doesn't support javascript.
loading
High dose sofosbuvir and sofosbuvir-plus-ribavirin therapy inhibit Hepatitis E Virus (HEV) replication in a rabbit model for acute HEV infection.
Liang, Zhaochao; Shu, Jingyi; He, Qiyu; Zhang, Fan; Dai, Lizhong; Wang, Ling; Lu, Fengmin; Wang, Lin.
Afiliação
  • Liang Z; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
  • Shu J; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
  • He Q; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
  • Zhang F; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
  • Dai L; Peking University-Sansure Biotech Joint Laboratory of Molecular Medicine, Peking University, Beijing, China.
  • Wang L; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China. Electronic address: lingwang@bjmu.edu.cn.
  • Lu F; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China; Peking University-Sansure Biotech Joint Laboratory of Molecular Medicine, Peking University, Beijing, China. Electronic address: lu.fengmin@hsc.pku.edu
  • Wang L; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China; Peking University-Sansure Biotech Joint Laboratory of Molecular Medicine, Peking University, Beijing, China. Electronic address: lin_wang@pku.edu.cn.
Antiviral Res ; 199: 105274, 2022 03.
Article em En | MEDLINE | ID: mdl-35247472

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Hepatite E / Hepatite E Limite: Animals / Humans Idioma: En Revista: Antiviral Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Hepatite E / Hepatite E Limite: Animals / Humans Idioma: En Revista: Antiviral Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Holanda